Clinical Trial Update: Venetoclax and Decitabine in R/R T-ALL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of venetoclax and decitabine for relapsed/refractory T-cell acute lymphoblastic leukemia is currently recruiting at Seoul National Univer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Dacogen (decitabine)
• Venclexta (venetoclax)

Snippet

Sponsor: Seoul National University Hospital | Conditions: T Lymphoblastic Leukemia/Lymphoma | Phase 2 | Status: RECRUITING